Equillium Inc (EQ)
0.6794
-0.10
(-12.94%)
USD |
NASDAQ |
Nov 14, 16:00
0.6794
0.00 (0.00%)
After-Hours: 18:00
Equillium Enterprise Value: -5.654M for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | -5.654M |
| November 12, 2024 | -3.192M |
| November 11, 2024 | -6.713M |
| November 08, 2024 | -6.288M |
| November 07, 2024 | -6.182M |
| November 06, 2024 | -6.681M |
| November 05, 2024 | -6.918M |
| November 04, 2024 | -6.727M |
| November 01, 2024 | -3.897M |
| October 31, 2024 | -2.799M |
| October 30, 2024 | 15.59M |
| October 29, 2024 | 15.41M |
| October 28, 2024 | 14.88M |
| October 25, 2024 | 8.502M |
| October 24, 2024 | 9.919M |
| October 23, 2024 | 3.542M |
| October 22, 2024 | 5.668M |
| October 21, 2024 | 6.376M |
| October 18, 2024 | 6.731M |
| October 17, 2024 | 4.959M |
| October 16, 2024 | 5.668M |
| October 15, 2024 | -2.444M |
| October 14, 2024 | -2.458M |
| October 11, 2024 | -0.7086M |
| October 10, 2024 | -1.382M |
| Date | Value |
|---|---|
| October 09, 2024 | -1.417M |
| October 08, 2024 | 0.3577M |
| October 07, 2024 | -0.2126M |
| October 04, 2024 | -2.664M |
| October 03, 2024 | -3.525M |
| October 02, 2024 | -3.436M |
| October 01, 2024 | -3.716M |
| September 30, 2024 | -3.826M |
| September 27, 2024 | -3.819M |
| September 26, 2024 | -5.314M |
| September 25, 2024 | -4.605M |
| September 24, 2024 | -4.248M |
| September 23, 2024 | -4.998M |
| September 20, 2024 | -3.188M |
| September 19, 2024 | -2.480M |
| September 18, 2024 | -3.188M |
| September 17, 2024 | -3.011M |
| September 16, 2024 | -2.834M |
| September 13, 2024 | -2.480M |
| September 12, 2024 | -2.480M |
| September 11, 2024 | -2.852M |
| September 10, 2024 | -2.040M |
| September 09, 2024 | -1.615M |
| September 06, 2024 | -0.496M |
| September 05, 2024 | 1.417M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-42.77M
Minimum
Mar 10 2023
436.89M
Maximum
Jul 13 2020
33.49M
Average
27.64M
Median
Nov 01 2022
Enterprise Value Benchmarks
| Matinas BioPharma Holdings Inc | -10.75M |
| Tenon Medical Inc | 2.957M |
| Alphatec Holdings Inc | 1.741B |
| Madrigal Pharmaceuticals Inc | 5.992B |
| Spero Therapeutics Inc | 7.277M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.468M |
| Revenue (Quarterly) | 13.85M |
| Total Expenses (Quarterly) | 13.95M |
| EPS Diluted (Quarterly) | 0.01 |
| Profit Margin (Quarterly) | 3.38% |
| Earnings Yield | -36.80% |
| Normalized Earnings Yield | -36.80 |